If you've started a GLP-1 medication, or you're supporting someone who has, you've probably heard about the headline effects: appetite changes, steady weight loss, better blood sugar control. What gets talked about far less is what's happening lower down, specifically inside your mouth.

Dentists are increasingly flagging a cluster of oral symptoms in patients taking these medications, informally nicknamed "Ozempic mouth" or "Ozempic teeth." It's not that the drug harms your teeth directly, there's no evidence of that. It's that GLP-1 medications change several things in the body at once (saliva, hydration, digestion, appetite), and your oral microbiome is caught right in the middle of all of it (1).

This article explains what GLP-1s actually do, why the mouth is affected, and what that tends to look like in practice.

How Do GLP-1 Medications Like Ozempic and Mounjaro Work?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after you eat. It tells your pancreas to release insulin, slows down how quickly food leaves your stomach, and sends a "you're full" signal to your brain (2).

Medications like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are designed to mimic this hormone, but at much higher and more sustained levels than your body produces on its own. That's what makes them so effective for managing type 2 diabetes and supporting weight loss. However, it is also why they affect so many systems beyond the gut.

The detail that matters for oral health: GLP-1 receptors are not only found in the pancreas and brain. They're also present in the salivary glands and in the taste buds themselves, which is one proposed explanation for why saliva production and taste can both change on these medications (3).

How GLP-1 Medications Affect Your Oral Microbiome

Your mouth relies on a careful, self-regulating balance of hundreds of bacterial species, and saliva is the main thing keeping that balance in check. GLP-1 medications interfere with that balance through a few connected mechanisms.

1. Reduced saliva flow

This is the most consistently reported oral side effect. Researchers have proposed that semaglutide may bind to GLP-1 receptors in the salivary glands for a prolonged period. This could potentially interfere with the normal signalling these glands rely on to produce saliva, making them less responsive over time (1,4).

Saliva isn't just moisture. It buffers acid, washes away food debris, and delivers minerals like calcium and phosphate back to your teeth. When flow drops, all of that protection drops with it. Eventually, the mix of bacteria in your mouth shifts toward species that thrive in a drier, less buffered environment (5).

2. Eating less means fewer saliva triggers

Chewing and eating are two important natural triggers for saliva production. Because GLP-1 medicines reduce appetite and food intake, it is possible that eating and chewing less frequently could also reduce some of the natural stimulation of saliva production, independently of any direct effect the medication may have on the salivary glands (6).

3. Nausea, reflux and vomiting

Gastrointestinal side effects are common, especially during dose increases. Stomach acid has a pH as low as 2, and both reflux and vomiting expose the mouth to that acidity repeatedly. This doesn't just affect enamel. A more acidic oral environment also favours acid-tolerant, decay-associated bacteria over the more neutral-pH-loving species that make up a healthy microbiome (7).

4. Nutritional shifts

Smaller appetites and reduced food intake can also make it harder to get enough of the nutrients needed to support healthy gums and bone, including calcium and vitamin D. Emerging research in people taking GLP-1 medications has found inadequate intakes of several micronutrients, including calcium and vitamin D (8). Changes in food choices may add to this risk, particularly when nutrient-dense foods are displaced by more refined or highly processed options.

Symptoms to Look Out For

Putting these potential mechanisms together, dentists and oral-health researchers are increasingly recognising a cluster of oral symptoms in some people taking GLP-1 medications:

• Dry mouth: one of the clearest emerging oral concerns, with reduced salivary flow reported in case reports and recognised as a potential adverse effect of GLP-1 medicines.
• Bad breath: reduced saliva can impair the mouth's natural cleansing and odour-control mechanisms, while reflux, nausea and vomiting may provide additional contributors to halitosis.
• Increased plaque and higher cavity risk: saliva normally helps clear food debris, buffer acids and protect tooth surfaces, so reduced salivary flow may increase susceptibility to plaque accumulation and dental caries.
• Gum inflammation: changes in saliva, nutrition and oral hygiene could potentially influence periodontal health, although the direct relationship between GLP-1 medicines and gum disease is still being investigated.
• Enamel erosion and sensitivity: nausea, vomiting and reflux can expose teeth to gastric acid, contributing to erosive tooth wear and sensitivity. This is different from ordinary tooth decay.
• Taste changes: altered or unpleasant taste, including metallic or bitter tastes, has been reported with GLP-1 medicines. Studies suggest GLP-1 signalling may influence taste perception, although the precise mechanism is not yet understood (4,9).

The takeaway

None of this means GLP-1 medications are bad for your mouth by design. It means several ordinary side effects, such as reduced saliva, occasional nausea, and appetite change, happen to intersect at exactly the point where your oral microbiome depends on stability. Understanding the mechanism is the useful part: once you know why dry mouth or bad breath is showing up, it stops being a mystery and becomes something you can actively manage.

If you're experiencing persistent dry mouth, taste changes, or any new dental symptoms while on a GLP-1 medication, it's worth flagging with both your prescribing doctor and your dentist.